Literature DB >> 25370585

Frequency and predictors of stroke after acute myocardial infarction: specific aspects of in-hospital and postdischarge events.

Olivier Hachet1, Charles Guenancia1, Karim Stamboul1, Benoit Daubail1, Carole Richard1, Yannick Béjot1, Valentin Yameogo1, Aurélie Gudjoncik1, Yves Cottin1, Maurice Giroud1, Luc Lorgis2.   

Abstract

BACKGROUND AND
PURPOSE: Stroke is a serious complication after acute myocardial infarction (AMI) and is closely associated with decreased survival. This study aimed to investigate the frequency, characteristics, and factors associated with in-hospital and postdischarge stroke in patients with AMI.
METHODS: Eight thousand four hundred eighty-five consecutive patients admitted to a cardiology intensive care unit for AMI, between January 2001 and July 2010. Stroke/transient ischemic attack were collected during 1-year follow-up.
RESULTS: One hundred twenty-three in-hospital strokes were recorded: 65 (52.8%) occurred on the first day after admission for AMI, and 108 (87%) within the first 5 days. One hundred six patients (86.2%-incidence rate 1.25%) experienced in-hospital ischemic stroke, and 14 patients (11.4%-incidence rate 0.16%) were diagnosed with an in-hospital hemorrhagic stroke. In-hospital ischemic stroke subtypes according to the Trial of Org 10 172 in Acute Stroke Treatment (TOAST) classification showed that only 2 types of stroke were identified more frequently. As expected, the leading subtype of in-hospital ischemic stroke was cardioembolic stroke (n=64, 60%), the second was stroke of undetermined pathogenesis (n=38, 36%). After multivariable backward regression analysis, female sex, previous transient ischemic attack (TIA)/stroke, new-onset atrial fibrillation, left ventricular ejection fraction (odds ratio per point of left ventricular ejection fraction), and C-reactive protein were independently associated with in-hospital ischemic stroke. When antiplatelet and anticoagulation therapy within the first 48 hours was introduced into the multivariable model, we found that implementing these treatments (≥1) was an independent protective factor of in-hospital stroke. In-hospital hemorrhagic stroke was dramatically increased (5-fold) when thrombolysis was prescribed as the reperfusion treatment. However, the different parenteral anticoagulants were not predictors of risk in univariable analysis. Finally, only 45 postdischarge strokes were recorded. Postdischarge stroke subtypes showed a more heterogeneous distribution of mechanisms. The annual rate of stroke post-AMI remained stable throughout the 10-year study period.
CONCLUSIONS: The present study describes specific predictors of in-hospital and postdischarge stroke in patients with AMI. It showed a marked increase in the risk of death, both during hospitalization and in the year after AMI. After hospital discharge, stroke remains a rare event and is mostly associated with high cardiovascular risk.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  myocardial infarction; risk factors; stroke

Mesh:

Year:  2014        PMID: 25370585     DOI: 10.1161/STROKEAHA.114.006707

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis.

Authors:  Xiangwen Liang; Wenchao Xie; Zhihai Lin; Ming Liu
Journal:  Anatol J Cardiol       Date:  2021-02       Impact factor: 1.596

2.  A clinical trial comparing complete revascularization at the time of primary percutaneous coronary intervention versus during the index hospital admission in patients with multi-vessel coronary artery disease and STEMI uncomplicated by cardiogenic shock.

Authors:  Mihnea Traian Nichita Brendea; Mircea I Popescu; Virgil Popa; Polojintef Corbu Dorina Carmen
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

3.  Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports.

Authors:  Salim Arous; Meryem Haboub; Mohamed El Ghali Benouna; Tarik Bentaoune; Rachida Habbal
Journal:  J Med Case Rep       Date:  2017-06-11

4.  Clinical features and risk factors of neurological involvement in Sjögren's syndrome.

Authors:  Wenjing Ye; Siyan Chen; Xinshi Huang; Wei Qin; Ting Zhang; Xiaofang Zhu; Xiaochun Zhu; Chongxiang Lin; Xiaobing Wang
Journal:  BMC Neurosci       Date:  2018-04-27       Impact factor: 3.288

5.  Cerebral microbleeds and acute myocardial infarction: Screening and disease progression.

Authors:  Abbass Alaa El Din; Hugo Debeaumarche; Pierre Thouant; Maud Maza; Frédéric Ricolfi; Marianne Zeller; Florence Bichat; Nathalie Baudouin; Yannick Bejot; Yves Cottin
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-29

6.  Updates on Prevention of Cardioembolic Strokes.

Authors:  Mehmet Akif Topcuoglu; Liping Liu; Dong-Eog Kim; M Edip Gurol
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

7.  In-Hospital acute ischemic stroke following ST-elevation myocardial infarction.

Authors:  Aiham Albaeni; Ché Matthew Harris; Hesham Nasser; Sirhley Sifontes; S Mustajab Hasan; Sai Guduru; Khalid Abusaada; Khaled Chatila; Syed Gilani; Wissam I Khalife
Journal:  Int J Cardiol Heart Vasc       Date:  2020-12-10

8.  Outcome of Stable Patients With Acute Myocardial Infarction and Coronary Artery Bypass Surgery Within 48 Hours: A Single-Center, Retrospective Experience.

Authors:  Christina Grothusen; Christine Friedrich; Johannes Loehr; Jette Meinert; Eva Ohnewald; Ulysses Ulbricht; Tim Attmann; Assad Haneya; Katharina Huenges; Sandra Freitag-Wolf; Jan Schoettler; Jochen Cremer
Journal:  J Am Heart Assoc       Date:  2017-10-03       Impact factor: 5.501

9.  The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction.

Authors:  Robin Henriksson; Fredrik Björklund; Thomas Mooe
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

10.  Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction.

Authors:  Robin Henriksson; Anders Ulvenstam; Lars Söderström; Thomas Mooe
Journal:  BMC Cardiovasc Disord       Date:  2019-03-04       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.